The three-dimensional structure of phosphoribosylglycinamide formyltransferase (10-formyltetrahydrofolate:5'-phosphoribosylglycinamide formyltransferase, EC 2.1.2.2) has been solved both as an apoenzyme at 2.8-A resolution and as a ternary complex with the substrate glycinamide ribonucleotide and a folate inhibitor at 2.5-A resolution.
The importance of folates in cellular metabolism has been recognized for nearly 50 yr. Derivatives of tetrahydrofolate, carrying single carbon units at various oxidation levels, are used in the biosynthesis of purines, pyrimidines, and amino acids. The first inhibitors of these processes designed as potential antimetabolites offolic acid (aminopterin and methotrexate) blocked dihydrofolate reductase (DHFR), the enzyme responsible for maintaining the 23, 237 ; GART), which catalyzes the transfer of a formyl group from lO-formyltetrahydrofolate (1OfTHF) to glycinamide ribonucleotide (GAR), a reaction in the purine biosynthetic pathway. An antifolate, 5,10-dideazatetrahydrofolate (1, 2) , has been shown to inhibit GART, de novo purine biosynthesis, and proliferation of tumor cells in culture (3) and is currently completing phase I clinical trials in a number of centers. This enzyme is, therefore, a good target for anti-cancer therapy and structure-based drug design.
In prokaryotes, GART is found as a single protein but in most eukaryotes it is found as the C-terminal portion of a large multifunctional protein (Mr > 100,000) also containing GAR synthetase and aminoimidazole ribonucleotide synthetase activities. The sequences of GART from prokaryotes and eukaryotes are homologous (4, 5) , and the structures are expected to be similar.
Here we report the three-dimensional structure of Escherichia coli GART as an apoenzyme (2.8-A resolution) and also as a ternary complex (2.5-A resolution) with the substrate GAR and a folate-based inhibitor, 5-deaza-5,6,7,8-tetrahydrofolate (5dTHF) (Fig. 1) . The GART structure is a modification of the classic doubly wound a/3 sheet with the active site located at the C-terminal edge, near the middle of the seven- stranded 83-sheet. We describe the major changes in the structure between the complexed and uncomplexed forms, interpret structure-activity relationships (SAR), and discuss the mechanism for catalysis based on our structural results.
MATERIALS AND METHODS The coding region ofE. coli GART was amplified from E. coli K-12 chromosomal DNA with PCR method (6) . Primer sequences were derived from E. coli purN gene (5) . Amplified DNA was confirmed and placed downstream of the T7 bacteriophage gene 10 promoter (7) as the second cistron using modified E. coli DHFR translation initiation region as the first cistron (8, 9) . The E. coli strain AP401-harboring expression plasmid was induced as described (9) .
GART was purified by using a DEAE-Sephacel column elution with a 0.03-0.8 M NaCl gradient followed by a Sephadex G75 column and a fast protein liquid chromotography mono Q elution with a 0.03-1 M NaCl gradient. The specific activity of the purified enzyme was 10 Jumol/min per mg. All steps were done at 40C in 50 mM Tris, pH 7.5/30 mM NaCl/1 mM dithiothreitol. A similar purification has since been published (10) .
All crystals were grown at 20'C by hanging-drop vapor diffusion. Apo crystals grew from 30 mg of protein per ml in 50 mM Tris (pH 7.5), 1 mM dithiothreitol, and a reservoir of 0.8 M Na+,K+ phosphate (pH 6 (14) . The main-chain connectivity was continuous, except for a disordered loop 110-132. Side-chain density matched the known sequence well. It was found that all 25 heavy-atom-binding sites were located near atoms in residues (histidine, methionine, cysteine) that are potentially reactive toward these heavy atoms, except for two minor sites that may not be real.
The ternary complex (GART, substrate GAR, and inhibitor 5dTHF) was solved by molecular replacement, using the apo-GART model, from a second crystal form (space group P1, a = 76. (15) . A second pair of molecules was then included, at the same initial orientation, and all four orientations were refined.
With these orientations, the translation function clearly showed the intermolecular vectors between the four molecules and resulted in good crystal packing. After Fig. 2A , and the main-chain fold of ternary GART is shown in Fig. 2 B and C. The primary feature is a central core of smoothly twisting, seven-stranded p8-pleated sheet surrounded on both sides by a-helices. The strands of the sheet twist almost 900 from one end of the molecule to the other; the twist has the usual handedness (19) .
The fold is a modification of the doubly wound a/p sheet (19) . Starting from the N terminus, there is a p-a-P--a-p mononucleotide-binding domain formed from three parallel p8-strands connected by two crossover a-helices, a supersecondary structure seen in a variety of proteins (19) (20) (21) . Succeeding p/a units (J34, a4, and 85) continue this motif. The four crossovers between the initial five parallel strands of the sheet are all helical, and the crossover chirality is the commonly observed right-handed form (22) . P6 runs antiparallel to the adjacent ,5 and p37. Thus all p-strands in this sheet have the same polarity, except the antiparallel (6. The N-terminal P-strand (J1) of the sheet is one of the central strands, and the C-terminal strand (87) is at the edge of the sheet. Following strand seven is a long, slightly bent helix of 27 residues (161-187). A nearly conserved proline, a residue that often introduces kinks when found in long helices (23), is located several residues after the bend. The C-terminal residues then extend into several short antiparallel strands, which are more exposed to the solvent than the primary sheet.
The location of the active site is shown in Fig. 2b with the substrate and inhibitor drawn as white bonds. The ligands interact with (34 and (35 at their C-terminal ends, residues from al and a6, and with the three loops in the region (between (34 and a4, between (5 and a5, and the loop containing Asp-144 between (6 and (7).
Apo-ternary comparison. Overall the ternary and two independent apo molecules are quite similar, with a rootmean-square deviation between 186 Ca atoms of 0.92 A (apo-apo), 0.91 A (apo-ternary), and 1.12 A (apo-ternary). However, there are regions where the structures differ significantly, especially around the active site. The two most important active-site differences are displayed in Fig. 3. (i) The long loop 110-132 is disordered in both apo molecules and clearly seen in the ternary molecule, although even there it is less well ordered (main chain <B> = 33 A2) than the average main-chain atom (<B> = 26 A2). (ii) Structural variability also exists in the 142-144 loop, along with correlated movements at His-108. This difference may be particularly significant because Asp-144 is known as an important catalytic residue, as discussed below. In Fig. 3 differences are seen between the two apo molecules, as well as between the apo and ternary molecules. In one apo molecule, the loop is in a closed conformation with Asp-144 directed inward and forming a closely associated tetrad of conserved side chains (Asn-106, His-108, His-137, and Asp-144). In the other apo molecule, this loop is open with Asp-144 on the surface and more exposed to solvent. The density is well ordered in both molecules, and the differences are probably related to influences of symmetry-related molecules in the crystal. It is difficult to say which of these conformations, if either, would be the predominant apo structure in solution, but the closed conformation is less influenced by crystal-packing effects. These three molecules show the high degree of conformational flexibility that exists in this enzyme active site. This is an important consideration in understanding the reaction mechanism and in structure-based inhibitor design.
Substrate GAR-Binding Site. The location of the enzyme active site can be seen in Fig. 2b . The substrate GAR and the folate inhibitor bind adjacent to the fourth and fifth strands of the (-sheet, at the C-terminal end.
It was first postulated that this region was the active-site region from the apocrystal form. A significant piece of density off the side chain of Ser-12 was observed in both apo molecules. This largest two peaks in the difference map, verifying that a single inorganic PO3-is bound to each apo molecule. This phosphate-binding site is located between the end of the first /3-strand and the N terminus of the subsequent helix in the f3-a-f3-a-/3 mononucleotide-binding domain. Phosphate binding using this type of secondary structure has been seen in a variety of nucleotide-binding proteins. This position along the loop between the ,3-strand and the a-helix is thought favorable due to its interactions with main-chain NH groups at the beginning of the helix and the favorable electrostatic interactions between the negative charge of the phosphate group and the dipole of the al helix (24) . This area is the most highly conserved portion of GART, with 6 of the 12 residues (5-16) identical in six species (4).
The GAR-binding site observed in the ternary complex (Fig. 4) has the phosphate group located at the inorganic phosphate-binding site found in the apocrystal form. The terminal three oxygen atoms of the phosphate interact primarily with the main-chain NH groups of residues 11, 12, and 13, the -t-oxygen of Ser-12, and the S-NH2 of Asn-13. The fourth phosphate oxygen is within hydrogen-bonding distance ofthe E-NH2 ofGln-170. The 3-hydroxyl group from the ribose ring is within hydrogen-bonding distance of both the c-NH2 of Gln-170 and one side-chain oxygen of Glu-173. The 2-hydroxyl is hydrogen bonded to the other side-chain oxygen of Glu-173. Both residues 170 and 173 are part of the long a6-helix and are located near the proline bend.
Inhibitor-Binding Site. The inhibitor 5dTHF and its interactions within the protein active site are displayed in Fig. 4 . The bicyclic portion of the inhibitor is well ordered, the benzoyl ring becomes less ordered, and the glutamate end is at the enzyme surface and is disordered. The orientation of the bicyclic ring is clear in the density maps with the 2-amino, 4-oxo, and bridge group at the 6 position being good markers. This ring is located with its surface over a volume of tightly packed hydrophobic residues. The edges of the ring are hydrogen bonded to main-chain atoms of the protein, which provides a rigid structure for binding, even though some of the hydrogen bonds are to atoms in the flexible loop containing Asp-144. Inhibitor hydrogen-bond acceptors include FIG. 4 . Stereo view of the active site of GART, substrate GAR, and inhibitor 5dTHF (green). Selected main-chain atoms (11-13, 84-97, 103-110, 137-145, 169-174) are shown in red. Hydrophobic residues are shown in yellow. These include a hydrophobic base below the bicyclic ring (Leu-85, Phe-88, Leu-92, Phe-96, Val-97, Leu-104, Val-139), residues surrounding the benzoyl ring above the bicyclic ring (Met-89, Ile-91, Leu-118, Leu-143), and residues near GAR (Gly-87, Ile-107, Pro-109). Hydrophilic residues are shown in blue; these include five residues, which we propose will be near the formyl group of the substrate 1OfTHF and may participate in catalysis (Asn-106, His-108, Ser-110, His-137, and Asp-144); also shown are five residues involved in GAR binding (Gly-11, Ser-12, Asn-13, Gln-170, .173081, 3OH-1730e2, 30H...170NE2, 50...170N62, PO1..13N, P01*..13081, PO2..12N, PO2..120y, and P03"..11N) .
the ring N1 to the enzyme residue 92 NH group (92NH) and the 4-oxo to 144 NH; donors include the 2-NH2 to 920 and 1410, N8 to 900, and possibly N3 to 1400.
The ternary complex was formed with GAR and a mixture of 6(R) and 6(S)-5dTHF. Either or both isomers could bind, with the C6 substituent in either an axial or equatorial conformation. Given the bicyclic-ring orientation, the axial S inhibitor cannot bind because it would severely overlap protein atoms. The equatorial R and S isomers can fit into the active site, but do not fit the density as well as the axial R isomer shown in Fig. 4 . This is the opposite C6 enantiomeric configuration of biologically reactive folates. The axial conformation is presumably the lower energy conformation since the solution conformation of tetrahydrofolate as determined by NMR has the C6 substituent axial (25) . This chirality around C6 is the same found in the slightly more potent isomer of the inhibitor 5,10-dideazatetrahydrofolate, a compound very similar to 5dTHF, which inhibits murine GART with a K, that is three times lower than the other isomer (1, 26) . The benzoyl ring of the folate inhibitor is located in a channel of hydrophobic residues including Met-89, Ile-91, Leu-118, and Leu-143.
SAR. SAR for inhibitor binding to murine GART (1) have been studied. Although monofunctional E. coli GART is only -20% the size of this trifunctional mammalian enzyme, it is homologous with the C-terminal portion, and much of the SAR data should be explained with the E. coli structure (Fig.   4 ).
The postulated hydrogen bonding at N8 and at the 2-NH2 group from SAR (1) Mechanistic Implications. The mechanism of GART is ordered-sequential: the folate substrate binds first, and the GAR binds second (27) ; the neutral amine is the reactive group (pH optimum 7.9-8.3). It is proposed that the reaction proceeds by direct nucleophilic attack by the amine of GAR on the formyl carbon of lOfTHF, forming a tetrahedral intermediate (28, 29) . Asp-144 functions in a critical role during catalysis; its mutation to asparagine produces an inactive enzyme that still binds substrates (30) .
The substrate 6(R)-lOfTHF was modeled into the active site where there are three conserved residues (Asn-106, His-108, and Asp-144) positioned such that they can assist the reaction. The side chain ofAsp-144 is positioned near the N10 of the folate but not close enough to and sterically blocked from the a-amine of GAR. It is more likely that His-108 N81 (3.4 A from the amine of GAR) accepts a proton from GAR, resulting from the nucleophilic attack. His-108 transfers this proton to Asp-144 directly or through the tetrahedral transi-
